Advances in structure-based drug discovery of carbonic anhydrase inhibitors

CT Supuran - Expert opinion on drug discovery, 2017 - Taylor & Francis
Introduction: The enzyme carbonic anhydrase (CA, EC 4.2. 1.1) is found in numerous
organisms across the tree of life, with seven distinct classes known to date. CA inhibition can …

Inhibition of carbonic anhydrase IX targets primary tumors, metastases, and cancer stem cells: three for the price of one

CT Supuran, V Alterio, A Di Fiore… - Medicinal Research …, 2018 - Wiley Online Library
Human carbonic anhydrase (CA) IX is a tumor‐associated protein, since it is scarcely
present in normal tissues, but highly overexpressed in a large number of solid tumors, where …

Carbonic anhydrase inhibitors as emerging agents for the treatment and imaging of hypoxic tumors

CT Supuran - Expert opinion on investigational drugs, 2018 - Taylor & Francis
Introduction: Hypoxic tumors overexpress two carbonic anhydrases (CA, EC 4.2. 1.1), CA IX
and XII, involved in complex processes connected to tumorigenesis (pH regulation …

[HTML][HTML] Carbonic anhydrase inhibition and the management of hypoxic tumors

CT Supuran - Metabolites, 2017 - mdpi.com
Hypoxia and acidosis are salient features of many tumors, leading to a completely different
metabolism compared to normal cells. Two of the simplest metabolic products, protons and …

[HTML][HTML] Cancer drug development of carbonic anhydrase inhibitors beyond the active site

S Singh, CL Lomelino, MY Mboge, SC Frost… - Molecules, 2018 - mdpi.com
Carbonic anhydrases (CAs) catalyze the reversible hydration of carbon dioxide to produce
bicarbonate and a proton. Multiple CA isoforms are implicated in a range of diseases …

Beyond silver sulfadiazine: A dive into more than 50 years of research and development on metal complexes of sulfonamides in medicinal inorganic chemistry

JHB Nunes, DH Nakahata, PP Corbi… - Coordination Chemistry …, 2023 - Elsevier
Sulfonamides revolutionized the treatment and management of bacterial infections. Prontosil
was the very first synthetic antibacterial agent ever used in the clinics and its metabolite …

[HTML][HTML] Past, present, and future: development of theranostic agents targeting carbonic anhydrase IX

J Lau, KS Lin, F Bénard - Theranostics, 2017 - ncbi.nlm.nih.gov
Theranostics is the integration of diagnostic information with pharmaceuticals to increase
effectiveness and safety of cancer treatments. Nuclear medicine provides a non-invasive …

From Unorthodox to Established: The Current Status of 18F-Trifluoroborate- and 18F-SiFA-Based Radiopharmaceuticals in PET Nuclear Imaging

V Bernard-Gauthier, JJ Bailey, Z Liu… - Bioconjugate …, 2016 - ACS Publications
Unorthodox 18F-labeling strategies not employing the formation of a carbon-18F bond are
seldom found in radiochemistry. Historically, the formation of a boron-or silicon-18F bond …

[18F]-Organotrifluoroborates as Radioprosthetic Groups for PET Imaging: From Design Principles to Preclinical Applications

DM Perrin - Accounts of Chemical Research, 2016 - ACS Publications
Conspectus Positron emission tomography (PET) is revolutionizing our ability to visualize in
vivo targets for target validation and personalized medicine. Of several classes of imaging …

Fluorine-18: A radionuclide with diverse range of radiochemistry and synthesis strategies for target based PET diagnosis

NS Goud, RK Joshi, RD Bharath, P Kumar - European Journal of Medicinal …, 2020 - Elsevier
Fluorine-18 is one of the most widely used radionuclides for the production of
radiopharmaceuticals for positron emission tomography (PET). The radiolabeling methods …